Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Walgreens Boots Alliance's Debt-to-EBITDA or its related term are showing as below:
BUE:WBA'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -12.99 Med: 2.13 Max: 13.26
Current: -9.95
During the past 13 years, the highest Debt-to-EBITDA Ratio of Walgreens Boots Alliance was 13.26. The lowest was -12.99. And the median was 2.13.
BUE:WBA's Debt-to-EBITDA is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 2.195
vs BUE:WBA: -9.95
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Walgreens Boots Alliance Debt-to-EBITDA Related Terms
Walgreens Boots Alliance Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BUE:WBA vs WGRX, PETS, BHIC: Debt-to-EBITDA Comparison
For the Pharmaceutical Retailers subindustry, Walgreens Boots Alliance's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Walgreens Boots Alliance Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Walgreens Boots Alliance's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Walgreens Boots Alliance's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (May. 2025) EBITDA data.
Walgreens Boots Alliance (BUE:WBA) has a Debt-to-EBITDA of 11.63 as of May. 2025. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Walgreens Boots Alliance. This is 446% above median its historical median of 2.13.
Is Walgreens Boots Alliance's Debt-to-EBITDA too high?
Walgreens Boots Alliance's current Debt-to-EBITDA of 11.63 is 446% above median its 10-year median of 2.13. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.20. Walgreens Boots Alliance's value of 11.63 is 429.8% above this industry median. Overall, Walgreens Boots Alliance has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Walgreens Boots Alliance's Debt-to-EBITDA compare to WGRX and PETS?
Walgreens Boots Alliance's Debt-to-EBITDA of 11.63 can be compared against companies in the Healthcare Providers & Services industry. The industry median Debt-to-EBITDA is 2.20. Walgreens Boots Alliance's value of 11.63 is 429.8% above this benchmark. While the company's 10-year median is 2.13 vs. the industry median of 2.20, Walgreens Boots Alliance has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.20, based on 476 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Walgreens Boots Alliance's current Debt-to-EBITDA of 11.63 is 429.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Walgreens Boots Alliance. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Walgreens Boots Alliance's current Debt-to-EBITDA is 11.63, which is 446% above median its own 10-year median of 2.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Walgreens Boots Alliance stock overvalued right now?
Walgreens Boots Alliance (BUE:WBA) has a current Debt-to-EBITDA of 11.63. The current Debt-to-EBITDA is 11.63, which is 446% above median its 10-year median of 2.13 and 429.8% above the Healthcare Providers & Services industry median of 2.20. Walgreens Boots Alliance's overall GF Score™ is 15/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Walgreens Boots Alliance (BUE:WBA), the current Debt-to-EBITDA is 11.63 as of May. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BUE:WBA has been successfully added to your 
